148 related articles for article (PubMed ID: 19932120)
1. N-acetyltransferase 2 activity and folate levels.
Cao W; Strnatka D; McQueen CA; Hunter RJ; Erickson RP
Life Sci; 2010 Jan; 86(3-4):103-6. PubMed ID: 19932120
[TBL] [Abstract][Full Text] [Related]
2. Only low levels of exogenous N-acetyltransferase can be achieved in transgenic mice.
Cao W; Chau B; Hunter R; Strnatka D; McQueen CA; Erickson RP
Pharmacogenomics J; 2005; 5(4):255-61. PubMed ID: 16041393
[TBL] [Abstract][Full Text] [Related]
3. Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism.
Wakefield L; Cornish V; Long H; Griffiths WJ; Sim E
Biochem Biophys Res Commun; 2007 Dec; 364(3):556-60. PubMed ID: 17961509
[TBL] [Abstract][Full Text] [Related]
4. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
5. A method for genotyping murine arylamine N-acetyltransferase type 2 (NAT2): a gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate.
Payton M; Smelt V; Upton A; Sim E
Biochem Pharmacol; 1999 Sep; 58(5):779-85. PubMed ID: 10449187
[TBL] [Abstract][Full Text] [Related]
6. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
7. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
Laurieri N; Dairou J; Egleton JE; Stanley LA; Russell AJ; Dupret JM; Sim E; Rodrigues-Lima F
PLoS One; 2014; 9(5):e96370. PubMed ID: 24823794
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of N-acetyltransferases 1 and 2 (NAT1 and NAT2) in cynomolgus and rhesus macaques.
Uno Y; Murayama N; Yamazaki H
Biochem Pharmacol; 2020 Jul; 177():113996. PubMed ID: 32339492
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2.
Walraven JM; Doll MA; Hein DW
J Pharmacol Exp Ther; 2006 Oct; 319(1):369-75. PubMed ID: 16829624
[TBL] [Abstract][Full Text] [Related]
10. Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.
Laurieri N; Kawamura A; Westwood IM; Varney A; Morris E; Russell AJ; Stanley LA; Sim E
BMC Pharmacol Toxicol; 2014 Nov; 15():68. PubMed ID: 25432241
[TBL] [Abstract][Full Text] [Related]
11. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
13. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
[TBL] [Abstract][Full Text] [Related]
14. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
15. 5-methyl-tetrahydrofolate and the S-adenosylmethionine cycle in C57BL/6J mouse tissues: gender differences and effects of arylamine N-acetyltransferase-1 deletion.
Witham KL; Butcher NJ; Sugamori KS; Brenneman D; Grant DM; Minchin RF
PLoS One; 2013; 8(10):e77923. PubMed ID: 24205029
[TBL] [Abstract][Full Text] [Related]
16. Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) expressed in Salmonella typhimurium.
Wild D; Feser W; Michel S; Lord HL; Josephy PD
Carcinogenesis; 1995 Mar; 16(3):643-8. PubMed ID: 7697826
[TBL] [Abstract][Full Text] [Related]
17. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.
Liu F; Zhang N; Zhou X; Hanna PE; Wagner CR; Koepp DM; Walters KJ
J Mol Biol; 2006 Aug; 361(3):482-92. PubMed ID: 16857211
[TBL] [Abstract][Full Text] [Related]
18. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster.
Hein DW; Doll MA; Xiao GH; Feng Y
Pharmacogenetics; 2003 Mar; 13(3):159-67. PubMed ID: 12618593
[TBL] [Abstract][Full Text] [Related]
19. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism.
Ward A; Summers MJ; Sim E
Biochem Pharmacol; 1995 Jun; 49(12):1759-67. PubMed ID: 7598738
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells.
Minchin RF
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):1-3. PubMed ID: 7717963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
